G
Graphite Bio
GRPHHealth Care· Cambridge, Massachusetts, United States
LAYOFFS TRACKED
3
LAST EVENT
Jun 1, 2023
MARKET CAP
—
EMPLOYEES
80
Graphite Bio is a clinical-stage biotechnology company developing in vivo and ex vivo gene-editing therapies using its proprietary delivery and editing platforms to treat severe genetic diseases. The company focuses on programs for sickle cell disease, beta-thalassemia, and other hematologic and genetic disorders.
Layoff history
EMPLOYEES AFFECTED PER QUARTER · HOVER FOR DETAILS
2
57
Q1 '23Q1 '24Q1 '25Q1 '26Q3 '26
Layoff timeline
3 EVENTSStories from here
No one has shared a story from Graphite Bio yet. Went through a layoff here? Your experience helps others feel less alone.
Share your story →Get alerts for Graphite Bio
We'll email you the moment a new layoff is reported here.